Athos Patsalides, M.D.

You are here

Athos Patsalides, MD

Dr. Patsalides is an Interventional Neuroradiologist in the Department of Neurological Surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. He is board-certified in Radiology and is Associate Professor of Radiology in Neurological Surgery at Weill Cornell Medical College.

TRAINING
Dr. Patsalides received his Medical Degree from the University of Athens, Greece, and a Master of Public Health degree from Johns Hopkins University. After completing his medical studies, he received a scholarship from the John E. Fogarty International Center for Advanced Study in the Health Sciences and moved to the United States to conduct research at the National Institutes of  Health. He completed his training at Georgetown University in Washington, D.C., and Weill Cornell Medical College in New York City. He is the recipient of multiple national awards from the Radiological Society of North America, the American Society of Neuroradiology, and the Society of  Neurointerventional Surgery. Dr. Patsalides is a diplomate of the American Board of Radiology and a senior member of the Society of Neurointerventional Surgery and the American Society of Neuroradiology. He is also a member of national committees of the Society of Neurointerventional  Surgery and the American College of Radiology.

RESEARCH
Dr. Patsalides is expert in the treatment of vascular diseases of the brain and spine and carotid stenosis. He has published extensively on the treatment of brain aneurysms, vascular malformations of the brain and spine, and stroke, and has given lectures and presentations at multiple national and international meetings and courses. He is also expert in minimally invasive procedures for spinal compression fractures (kyphoplasty, vertebroplasty) and for patients with osteoporosis, multiple myeloma, and spinal tumors. Dr. Patsalides’ clinical research interests include the development of new intra-arterial chemotherapy treatments for spinal, head, and neck tumors and novel minimally invasive treatments for spinal tumors. He is leading two novel FDA-approved clinical trials, one for intra-arterial chemotherapy for spinal tumors and the other for the treatment of idiopathic intracranial hypertension (pseudotumor cerebri) using angioplasty and stenting. 

Request an Appointment | Refer a Patient